WebAug 11, 2024 · Continuous Glucose Monitoring to Assess Glycemia in CKD (CANDY) was a prospective observational cohort study designed to characterize hypoglycemia in CKD and evaluate the performance of markers of glycemia in people with type 2 diabetes and moderate to severe CKD . WebJan 3, 2024 · Proportion of CGM values within 20% of blood glucose levels >100 mg/dl or within 20 mg/dl of blood glucose level for levels <=100 mg/dl. (Will examine different thresholds of CGM values within a certain range of blood glucose levels, i.e., 10%, 15%, 25%.) Secondary Outcome Measures : Hypoglycemia events [ Time Frame: 3 to 5 days ]
Glycaemic Markers in Persons With Type 2 Diabetes on Peritoneal Dialysis
WebSep 18, 2024 · Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD). … WebFeb 14, 2024 · Hypoglycaemia carries a significant risk and often serves as a barrier for achieving optimal glucose control in patients with diabetes mellitus [1,2,3].Patients with type 1 diabetes may experience clinical signs and symptoms of lower blood glucose values during the life-long course of diabetes [].In patients with type 2 diabetes, hypoglycaemia … pool homes rockledge fl
Dexcom Continuous Glucose Monitoring Dexcom
WebAims/hypothesis: We investigated associations among glucose time in range (TIR, 70-180 mg/dL), glycemic markers and prevalence of diabetic microangiopathy in people with diabetes undergoing hemodialysis (HD). Methods: A total of 107 people with type 2 diabetes undergoing HD (HbA 1c 6.4 %; glycated albumin [GA] 20.6 %) using … WebSep 27, 2024 · Systemic effects of peritoneally absorbed glucose are more poorly defined. Using continuous glucose monitoring (CGM), we aimed to describe 24-h glycaemic profiles of PD patients without diabetes and compare with non-dialysis controls with stage 5 chronic kidney disease (CKD-5). ... Mori T, Chida M, Oba I, et al. Diurnal variations of … WebMar 1, 2015 · Continuous glucose monitoring (CGM) The iPro2 ® CGM (MMT-7741) with sensors MMT-7002 or MMT-7003 (Medtronic, Minneapolis, MN, USA) was used during the CGM period for a 5-day CGM recording every 2 weeks. iPro2 ® CGM was applied by the dialysis nurse and withdrawn 5 days later during a dialysis session. Therefore CGM … shareberry